Other income stood at Rs 5.23 crore compared to Rs 1.06 crore. Interest cost was Rs 46 lakh compared to Rs 82 lakh. Depreciation rose 7% to Rs 6.72 crore. PBT was up 5% to Rs 49.78 crore.
Tax expenses were up 11% to Rs 14.98 crore owing to which the companys net profit reported was up 2% to Rs 34.81 crore. Further considering minority interest, Bottomline of the company increased 3% to Rs 34.25 crore.
Consolidated performance for the year ended Mar20
For year ended Mar20, net sales rose 6% to Rs 443.99 crore. The company operating margins increased 240 bps to 45.6%. As a result operating profits rose 11% to Rs 202.33 crore.
Other income rose 12% to Rs 5.64 crore. Interest cost was down 22% to Rs 3.04 crore. Depreciation rose 22% to Rs 25.78 crore. PBT was up 11% to Rs 179.16 crore.
The effective tax rate decreased to 25.7% from 28.4% owing to which the companys net profit rose 15% at Rs 133.05 crore. Further considering minority interest, Bottomline of the company fell 16% to Rs 129.29 crore.
The scrip is currently trading at Rs 208
Advanced Enzymes Technologies: Results
|2006 (03)||1906 (03)||Var. (%)||2003 (12)||1903 (12)||Var. (%)|
|Total Operating Income||110.50||110.34||0||443.99||419.59||6|
|PBT Before EO||49.78||47.47||5||179.16||161.96||11|
|EO (net of tax)||0.00||0.00||0.00||0.00|
|PAT after EO||34.81||33.97||2||133.05||115.90||15|
|PAT after MI||34.25||33.40||3||129.29||111.06||16|
|* Annualized On Current Equity Of Rs 22.33 Crore of face value of Rs 2 each|
EO: Extraordinary Items, PL: Profit to Loss
EPS Is Calculated After Excluding EO And Relevant Tax
# EPS not annualised due to seasonality of business
Figures In Rs Crore
Source: Capitaline Database
Powered by Capital Market - Live News